Summary

The global medical simulation market is projected to reach USD 7.23 billion by 2030 from USD 3.50 billion in 2025, at a CAGR of 15.6%. The medical simulation market is growing due to increasing demand for advanced clinical training and investments in supporting infrastructure. For example, the University of Texas at Arlington announced its Mobile Simulation Lab, launched in March 2025, aimed at delivering high-tech medical education in underserved parts of Texas, highlighting how simulation technologies are increasing access to hands-on education beyond traditional academic centers. “Healthcare simulation anatomical models held the largest share of the medical simulation market.” https://mnmimg.marketsandmarkets.com/Images/healthcare-medical-simulation-market-img-overview.webp Based on offering segment, healthcare simulation anatomical models held the largest share of the medical simulation market. This is because of their widespread use in foundational training and skills practice. These physical models help learners build core competencies in a risk-free environment before working with patients. For example, Kyoto Kagaku provides highly detailed anatomical phantoms for ultrasound and procedural skills training, and Limbs & Things offers realistic pelvic and neonatal models used in obstetrics and emergency care education, making anatomical models indispensable in medical and nursing curricula worldwide. “Procedural rehearsal technology held the largest share of the medical simulation market in 2024.” The procedural rehearsal technology segment accounted for the largest share of the medical simulation market in 2024, driven by the need for hands-on practice of complex medical procedures. These technologies enable clinicians to simulate surgeries on highly realistic, often patient-specific models with improved accuracy and reduced intraoperative risk. Acceleration of adoption will be furthered by the rise of minimally invasive surgery, an increased focus on reducing complications, and greater investment in advanced imaging and 3D modeling. For example, various platforms from Surgical Science Sweden AB enable surgeons to rehearse laparoscopic and endoscopic procedures in virtual environments, effectively bridging the gap between theory and real-world execution in training and preoperative planning. “Asia Pacific is growing at the fastest rate during the forecast period.” Asia Pacific is the fastest-growing region in the medical simulation market, driven by the rapid expansion of healthcare infrastructure, the growing need for skilled clinical resources, and the increasing adoption of state-of-the-art training solutions. For instance, in December 2025, the Indian government launched the second National Simulation Centre for nursing education in Bagalkot, equipped with high-fidelity simulators to help students improve their clinical skills, thereby indicating the general public’s support for this sector in this region. In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below: ? By Company Type - Tier 1: 55%, Tier 2: 30%, and Tier 3: 15% ? By Designation - C-level Executives: 50%, Directors: 35%, and Others: 15% ? By Region - North America: 48%, Europe: 32%, Asia Pacific: 15%, Middle East & Africa: 3%, and Latin America: 2% Note: Other designations include sales, marketing, and product managers. Tiers are defined based on a company’s total revenue as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =

ページTOPに戻る

Table of Contents

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 STUDY SCOPE 33
1.2.2 INCLUSIONS & EXCLUSIONS 34
1.2.3 YEARS CONSIDERED 35
1.3 CURRENCY CONSIDERED 35
1.4 STAKEHOLDERS 36
1.5 SUMMARY OF CHANGES 36
2 EXECUTIVE SUMMARY 37
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 37
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 38
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 39
2.4 HIGH-GROWTH SEGMENTS 40
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 41
3 PREMIUM INSIGHTS 42
3.1 ATTRACTIVE OPPORTUNITIES FOR MEDICAL SIMULATION MARKET 42
3.2 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY END USER AND COUNTRY 43
3.3 MEDICAL SIMULATION MARKET, BY COUNTRY 44
4 MARKET OVERVIEW 45
4.1 INTRODUCTION 45
4.2 MARKET DYNAMICS 45
4.3 MARKET DYNAMICS: IMPACT ANALYSIS 46
4.3.1 DRIVERS 46
4.3.1.1 Rising demand for realistic and risk-free training environments in medical education 46
4.3.1.2 Rapid technological advancements in medical education 47
4.3.1.3 Surging demand for minimally invasive treatments 47
4.3.1.4 Increasing focus on patient safety 48
4.3.1.5 Growing adoption of AI-driven VR platforms to improve clinical decision-making 48
4.3.2 RESTRAINTS 49
4.3.2.1 Limited availability of funds to establish simulation training centers 49
4.3.2.2 Poorly designed medical simulators 50
?
4.3.3 OPPORTUNITIES 50
4.3.3.1 Widening workforce gaps creating demand for simulation-based training solutions 50
4.3.3.2 Growing awareness about simulation training in emerging economies 51
4.3.4 CHALLENGES 51
4.3.4.1 High cost of simulators 51
4.3.4.2 Operational challenges 52
4.4 UNMET NEEDS & WHITE SPACES 52
4.5 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 53
4.6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 54
5 INDUSTRY TRENDS 55
5.1 PORTER’S FIVE FORCES ANALYSIS 55
5.1.1 BARGAINING POWER OF SUPPLIERS 56
5.1.2 BARGAINING POWER OF BUYERS 56
5.1.3 THREAT OF SUBSTITUTES 56
5.1.4 THREAT OF NEW ENTRANTS 56
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 56
5.2 MACROECONOMIC INDICATORS 57
5.2.1 GDP TRENDS & FORECAST 57
5.2.2 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 57
5.3 VALUE CHAIN ANALYSIS 58
5.4 ECOSYSTEM ANALYSIS 59
5.5 PRICING ANALYSIS 60
5.5.1 INDICATIVE PRICING ANALYSIS OF MEDICAL SIMULATION PRODUCTS, BY KEY PLAYER, 2025 61
5.5.2 INDICATIVE PRICING ANALYSIS OF MEDICAL SIMULATION PRODUCTS, BY REGION, 2025 61
5.6 KEY CONFERENCES & EVENTS, 2026?2027 62
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 62
5.8 INVESTMENT & FUNDING SCENARIO 63
5.9 CASE STUDY ANALYSIS 64
5.9.1 CASE STUDY 1: ENHANCING CLINICAL READINESS: NORTHUMBRIA UNIVERSITY'S SCALABLE SIMULATION PROGRAM IN PARTNERSHIP WITH OMB 64
5.9.2 CASE STUDY 2: OPTIMIZING PATIENT FLOW AND INFRASTRUCTURE: MEMORIAL HEALTH SYSTEM’S SIMULATION-DRIVEN EFFICIENCY GAINS WITH SIMUL8 65
5.10 IMPACT OF 2025 US TARIFFS ON MEDICAL SIMULATION MARKET 65
5.10.1 INTRODUCTION 65
5.10.2 KEY TARIFF RATES 66
5.10.3 PRICE IMPACT ANALYSIS 66
?
5.10.4 IMPACT ON COUNTRY/REGION 67
5.10.4.1 US 67
5.10.4.2 Europe 68
5.10.4.3 Asia Pacific 68
5.10.5 IMPACT ON END-USE INDUSTRIES 69
5.10.5.1 Academic institutes 69
5.10.5.2 Hospitals 69
5.10.5.3 Military organizations 69
6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION 70
6.1 KEY EMERGING TECHNOLOGIES 70
6.1.1 COMPUTER-BASED SIMULATIONS 70
6.1.2 HAPTIC FEEDBACK DEVICES 70
6.1.3 ARTIFICIAL INTELLIGENCE & VIRTUAL REALITY 70
6.2 COMPLEMENTARY TECHNOLOGIES 71
6.2.1 BIG DATA & INTEROPERABILITY PLATFORMS 71
6.2.2 LEARNING MANAGEMENT SYSTEMS (LMS) 71
6.3 ADJACENT TECHNOLOGIES 72
6.3.1 CLOUD COMPUTING 72
6.3.2 ROBOTICS 72
6.4 TECHNOLOGY/PRODUCT ROADMAP 72
6.5 PATENT ANALYSIS 73
6.5.1 PATENT PUBLICATION TRENDS FOR MEDICAL SIMULATION MARKET 73
6.5.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 74
6.6 FUTURE APPLICATIONS 76
6.6.1 AI-DRIVEN ADAPTIVE SIMULATION & PERFORMANCE ANALYTICS 76
6.6.2 DIGITAL TWIN-ENABLED PATIENT-SPECIFIC SIMULATION 76
6.6.3 IMMERSIVE XR-BASED COLLABORATIVE TRAINING ENVIRONMENTS 77
6.6.4 REMOTE, CLOUD-BASED SIMULATION, AND SCALABILITY 77
6.6.5 HAPTIC INNOVATION & HIGH-FIDELITY PHYSICAL-DIGITAL INTEGRATION 77
6.6.6 SIMULATION FOR CLINICAL DECISION SUPPORT & RISK REDUCTION 77
6.7 IMPACT OF AI/GEN AI ON MEDICAL SIMULATION MARKET 77
6.7.1 MARKET POTENTIAL OF AI/GEN AI 78
6.7.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 79
6.7.2.1 AI-driven surgical simulation and performance analytics at Surgical Science Sweden AB 79
6.7.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 80
6.7.3.1 AI-driven adaptive simulation and training platforms 80
6.7.3.2 Virtual patients, digital twins, and simulation intelligence 80
6.7.3.3 Remote simulation, collaboration, and skill validation 80
?
6.7.4 USER READINESS & IMPACT ASSESSMENT 81
6.7.4.1 User readiness 81
6.7.4.1.1 User A: Academic institutes 81
6.7.4.1.2 User B: Hospitals 81
6.7.4.1.3 User C: Military organizations 81
6.7.4.2 Impact assessment 81
6.7.4.2.1 User A: Academic Institutes 81
6.7.4.2.2 User B: Hospitals 82
6.7.4.2.3 User C: Military organizations 82
7 REGULATORY LANDSCAPE 83
7.1 REGIONAL REGULATIONS & COMPLIANCE 83
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
7.1.2 INDUSTRY STANDARDS 86
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 87
8.1 DECISION-MAKING PROCESS 87
8.2 KEY STAKEHOLDERS IN BUYING PROCESS & THEIR EVALUATION CRITERIA 87
8.2.1 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS 87
8.2.2 BUYING CRITERIA 88
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 89
8.4 UNMET NEEDS FROM END-USE INDUSTRIES 90
8.4.1 UNMET NEEDS 90
8.4.2 END-USER EXPECTATIONS 91
8.5 MARKET PROFITABILITY 91
9 MEDICAL SIMULATION MARKET, BY OFFERING 92
9.1 INTRODUCTION 93
9.2 HEALTHCARE SIMULATION ANATOMICAL MODELS 93
9.2.1 PATIENT SIMULATORS 94
9.2.1.1 Patient simulators market, by type 97
9.2.1.1.1 High-fidelity patient simulators 97
9.2.1.1.1.1 Growing adoption of high-fidelity patient simulators in educational training to drive growth 97
9.2.1.1.2 Medium-fidelity patient simulators 98
9.2.1.1.2.1 Cost benefits of medium-fidelity simulation to drive demand 98
9.2.1.1.3 Low-fidelity patient simulators 100
9.2.1.1.3.1 Budgetary constraints and ease of use to drive demand 100
9.2.1.2 Patient simulators market, by application 101
9.2.1.2.1 Laparoscopic surgical simulators 101
9.2.1.2.1.1 Increasing prevalence of minimally invasive surgeries to drive growth 101
9.2.1.2.2 Gynecology simulators 102
9.2.1.2.2.1 Increasing incidence of fibroids and polyps in women to drive demand 102
9.2.1.2.3 Cardiovascular simulators 103
9.2.1.2.3.1 Increasing prevalence of diabetes to boost demand 103
9.2.1.2.4 Orthopedic surgical simulators 104
9.2.1.2.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 104
9.2.1.2.5 Spine surgical simulators 105
9.2.1.2.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 105
9.2.1.2.6 Endovascular simulators 106
9.2.1.2.6.1 Reduced mortality rates associated with endovascular simulators to boost demand 106
9.2.1.2.7 Other patient simulators 106
9.2.2 TASK TRAINERS 107
9.2.2.1 Inability to imitate emotional attributes of patients to restrain growth 107
9.2.3 INTERVENTIONAL/SURGICAL SIMULATORS 109
9.2.3.1 Laparoscopic surgical simulators 110
9.2.3.1.1 Increasing preference for minimally invasive surgeries to drive growth 110
9.2.3.2 Gynecology surgical simulators 111
9.2.3.2.1 Increasing incidence of fibroids and polyps in women to drive demand for gynecology simulators 111
9.2.3.3 Cardiovascular surgical simulators 112
9.2.3.3.1 Increasing prevalence of obesity and diabetes to boost demand 112
9.2.3.4 Orthopedic surgical simulators 113
9.2.3.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 113
9.2.3.5 Spine surgical simulators 114
9.2.3.5.1 Growing use of spine surgical simulators in training surgeons to boost demand 114
9.2.3.6 Endovascular surgical simulators 115
9.2.3.6.1 Ability to reduce mortality rates to drive demand for endovascular surgical simulators 115
9.2.3.7 Other interventional/surgical simulators 117
9.2.4 ULTRASOUND SIMULATORS 118
9.2.4.1 Inferior quality images due to low dynamics and spatial resolution to restrain growth 118
9.2.5 DENTAL SIMULATORS 119
9.2.5.1 Expanding dental tourism industry to drive growth 119
9.2.6 EYE SIMULATORS 120
9.2.6.1 Increasing incidence of eye disorders to drive growth 120
?
9.3 WEB-BASED SIMULATION 121
9.3.1 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF WEB-BASED SIMULATION 121
9.4 HEALTHCARE SIMULATION SOFTWARE 122
9.4.1 ABILITY TO REDUCE OVERALL SURGICAL PROCESS TRAINING TIME TO DRIVE ADOPTION 122
9.5 SIMULATION TRAINING SERVICES 123
9.5.1 VENDOR-BASED TRAINING 124
9.5.1.1 High focus on patient safety to drive demand 124
9.5.2 EDUCATIONAL SOCIETIES 125
9.5.2.1 Growing need for proper training and authenticity of knowledge to drive growth 125
9.5.3 CUSTOM CONSULTING SERVICES 126
9.5.3.1 Growing need to limit errors associated with traditional medical training systems to drive growth 126
10 MEDICAL SIMULATION MARKET, BY TECHNOLOGY 128
10.1 INTRODUCTION 129
10.2 VIRTUAL PATIENT SIMULATION 129
10.2.1 INCREASING FOCUS ON AUGMENTED REALITY/VIRTUAL REALITY TO DRIVE MARKET 129
10.3 3D PRINTING 131
10.3.1 INCREASING ADOPTION IN MEDICAL TRAINING TO DRIVE MARKET 131
10.4 PROCEDURAL REHEARSAL TECHNOLOGY 132
10.4.1 NEED FOR ADVANCING SURGICAL SKILLS WITH REHEARSAL TECH TO FUEL MARKET GROWTH 132
11 MEDICAL SIMULATION MARKET, BY END USER 134
11.1 INTRODUCTION 135
11.2 ACADEMIC INSTITUTES 135
11.2.1 GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO DRIVE DEMAND 135
11.3 HOSPITALS 136
11.3.1 RISING FOCUS ON MINIMIZING MEDICAL ERRORS TO DRIVE DEMAND 136
11.4 MILITARY ORGANIZATIONS 138
11.4.1 EXPLORATION OF NEW METHODS OF MEDICAL CARE DURING WARFARE TO DRIVE DEMAND 138
11.5 OTHER END USERS 139
?
12 MEDICAL SIMULATION MARKET, BY REGION 141
12.1 INTRODUCTION 142
12.2 NORTH AMERICA 142
12.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 147
12.2.2 US 147
12.2.2.1 Increasing demand for virtual tutors and high healthcare spending to boost growth 147
12.2.3 CANADA 151
12.2.3.1 Clinical simulation and competency-based training in Canada to fuel market growth 151
12.3 EUROPE 155
12.3.1 EUROPE: MACROECONOMIC OUTLOOK 160
12.3.2 GERMANY 160
12.3.2.1 High healthcare spending to drive market growth 160
12.3.3 FRANCE 164
12.3.3.1 Growing focus on use of innovative methods in medical training to drive growth 164
12.3.4 UK 168
12.3.4.1 Rising number of healthcare simulation centers and hospitals to drive growth 168
12.3.5 ITALY 172
12.3.5.1 Shortage of trained healthcare personnel to drive growth 172
12.3.6 SPAIN 176
12.3.6.1 Increasing number of surgical procedures to boost growth 176
12.3.7 REST OF EUROPE 180
12.4 ASIA PACIFIC 184
12.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 189
12.4.2 CHINA 189
12.4.2.1 Increasing demand for trained medical professionals to drive growth 189
12.4.3 JAPAN 193
12.4.3.1 Increasing demand for virtual tutors and technologically advanced simulators to drive growth 193
12.4.4 INDIA 197
12.4.4.1 Growing awareness regarding patient safety due to healthcare negligence to drive growth 197
12.4.5 AUSTRALIA 201
12.4.5.1 Accreditation-driven training and national workforce policies to fuel medical simulation adoption in Australia 201
12.4.6 SOUTH KOREA 205
12.4.6.1 Technology-driven innovation and national digital health initiatives to accelerate adoption of medical simulation in South Korea 205
12.4.7 REST OF ASIA PACIFIC 209
?
12.5 LATIN AMERICA 213
12.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 217
12.5.2 BRAZIL 217
12.5.2.1 High incidence of chronic diseases to drive market 217
12.5.3 MEXICO 221
12.5.3.1 Disruptive technologies and public-private partnerships to boost growth 221
12.5.4 REST OF LATIN AMERICA 225
12.6 MIDDLE EAST & AFRICA 229
12.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 233
12.6.2 GCC COUNTRIES 233
12.6.2.1 Focus on enhancing patient care to drive market 233
12.6.2.2 Saudi Arabia 237
12.6.2.2.1 Government-led digital transformation and strong investments in AI-driven healthcare to boost market 237
12.6.2.3 UAE 241
12.6.2.3.1 Quality-driven healthcare strategy and institutional investments to accelerate simulation demand in UAE 241
12.6.2.4 Rest of GCC Countries 245
12.6.3 SOUTH AFRICA 249
12.6.3.1 Evolving facility accreditation and workforce training needs to accelerate simulation adoption 249
12.6.4 REST OF MIDDLE EAST & AFRICA 253
13 COMPETITIVE LANDSCAPE 257
13.1 OVERVIEW 257
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023?2026 257
13.3 REVENUE ANALYSIS, 2021?2025 260
13.4 MARKET SHARE ANALYSIS, 2025 261
13.5 BRAND/PRODUCT COMPARISON 263
13.6 COMPANY VALUATION & FINANCIAL METRICS 264
13.6.1 FINANCIAL METRICS 264
13.6.2 COMPANY VALUATION 264
13.7 MARKET RANKING ANALYSIS, 2025 264
13.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 266
13.8.1 STARS 266
13.8.2 EMERGING LEADERS 266
13.8.3 PERVASIVE PLAYERS 266
13.8.4 PARTICIPANTS 267
13.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 268
13.8.5.1 Company footprint 268
13.8.5.2 Region footprint 268
13.8.5.3 Product & service footprint 269
13.8.5.4 Technology footprint 270
13.8.5.5 End-user footprint 270
13.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 271
13.9.1 PROGRESSIVE COMPANIES 271
13.9.2 RESPONSIVE COMPANIES 271
13.9.3 DYNAMIC COMPANIES 271
13.9.4 STARTING BLOCKS 272
13.9.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 273
13.9.5.1 Detailed list of key startups/SMEs 273
13.9.5.2 Competitive benchmarking of key startups/SMEs 273
13.10 COMPETITIVE SCENARIO 274
13.10.1 PRODUCT LAUNCHES & ENHANCEMENTS 274
13.10.2 DEALS 275
14 COMPANY PROFILES 276
14.1 KEY PLAYERS 276
14.1.1 SURGICAL SCIENCE SWEDEN AB 276
14.1.1.1 Business overview 276
14.1.1.2 Products offered 278
14.1.1.3 Recent developments 279
14.1.1.3.1 Product enhancements 279
14.1.1.3.2 Deals 279
14.1.1.4 MnM view 280
14.1.1.4.1 Right to win 280
14.1.1.4.2 Strategic choices 280
14.1.1.4.3 Weaknesses & competitive threats 280
14.1.2 LAERDAL MEDICAL 281
14.1.2.1 Business overview 281
14.1.2.2 Products offered 281
14.1.2.3 Recent developments 285
14.1.2.3.1 Product launches 285
14.1.2.3.2 Deals 285
14.1.2.4 MnM view 286
14.1.2.4.1 Right to win 286
14.1.2.4.2 Strategic choices 286
14.1.2.4.3 Weaknesses & competitive threats 286
14.1.3 GAUMARD SCIENTIFIC 287
14.1.3.1 Business overview 287
14.1.3.2 Products offered 287
14.1.3.3 Recent developments 295
14.1.3.3.1 Product launches 295
14.1.3.3.2 Deals 295
14.1.3.4 MnM view 296
14.1.3.4.1 Right to win 296
14.1.3.4.2 Strategic choices 296
14.1.3.4.3 Weaknesses & competitive threats 296
14.1.4 KYOTO KAGAKU CO., LTD. 297
14.1.4.1 Business overview 297
14.1.4.2 Products offered 297
14.1.4.3 MnM view 301
14.1.4.3.1 Right to win 301
14.1.4.3.2 Strategic choices 301
14.1.4.3.3 Weaknesses & competitive threats 302
14.1.5 LIMBS & THINGS LTD. 303
14.1.5.1 Business overview 303
14.1.5.2 Products offered 303
14.1.5.3 Recent developments 306
14.1.5.3.1 Product launches 306
14.1.5.3.2 Deals 307
14.1.5.4 MnM view 307
14.1.5.4.1 Right to win 307
14.1.5.4.2 Strategic choices 307
14.1.5.4.3 Weaknesses & competitive threats 307
14.1.6 MENTICE AB 308
14.1.6.1 Business overview 308
14.1.6.2 Products offered 309
14.1.6.3 Recent developments 311
14.1.6.3.1 Product launches & approvals 311
14.1.6.3.2 Deals 311
14.1.7 SIMULAB CORPORATION 313
14.1.7.1 Business overview 313
14.1.7.2 Products offered 313
14.1.7.3 Recent developments 319
14.1.7.3.1 Product launches & enhancements 319
14.1.8 SIMULAIDS 320
14.1.8.1 Business overview 320
14.1.8.2 Products offered 320
14.1.8.3 Recent developments 326
14.1.8.3.1 Product launches 326
14.1.9 OPERATIVE EXPERIENCE, INC. 327
14.1.9.1 Business overview 327
14.1.9.2 Products offered 327
14.1.9.3 Recent developments 328
14.1.9.3.1 Other developments 328
14.1.10 ELEVATE HEALTHCARE 329
14.1.10.1 Business overview 329
14.1.10.2 Products offered 330
14.1.11 ANATOMAGE 331
14.1.11.1 Business overview 331
14.1.11.2 Products offered 331
14.1.11.3 Recent developments 332
14.1.11.3.1 Product launches & enhancements 332
14.1.11.3.2 Other developments 333
14.1.12 3B SCIENTIFIC 334
14.1.12.1 Business overview 334
14.1.12.2 Products offered 335
14.1.13 VIRTAMED AG 336
14.1.13.1 Business overview 336
14.1.13.2 Products offered 336
14.1.13.3 Recent developments 336
14.1.13.3.1 Product enhancements 336
14.1.13.3.2 Deals 337
14.1.14 SYNBONE AG 338
14.1.14.1 Business overview 338
14.1.14.2 Products offered 338
14.1.15 ERLER-ZIMMER MEDICAL GMBH 339
14.1.15.1 Business overview 339
14.1.15.2 Products offered 340
14.1.16 MEDICAL-X 341
14.1.16.1 Business overview 341
14.1.16.2 Products offered 341
14.1.17 KAVO DENTAL 343
14.1.17.1 Business overview 343
14.1.17.2 Products offered 343
14.1.18 ALTAY SCIENTIFIC 344
14.1.18.1 Business overview 344
14.1.18.2 Products offered 344
14.1.19 TRUCORP LIMITED 349
14.1.19.1 Business overview 349
14.1.19.2 Products offered 349
14.1.19.3 Recent developments 350
14.1.19.3.1 Product launches 350
14.1.19.3.2 Deals 350
14.1.20 SIMENDO 351
14.1.20.1 Business overview 351
14.1.20.2 Products offered 351
14.2 OTHER PLAYERS 352
14.2.1 HAAG-STREIT AG 352
14.2.2 SONOSIM 352
14.2.3 HRV SIMULATION 353
14.2.4 SYNAPTIVE MEDICAL 353
14.2.5 INOVUS LIMITED 354
15 RESEARCH METHODOLOGY 355
15.1 RESEARCH APPROACH 355
15.1.1 SECONDARY RESEARCH 355
15.1.1.1 Key data from secondary sources 356
15.1.2 PRIMARY RESEARCH 357
15.1.2.1 Primary sources 357
15.1.2.2 Key data from primary sources 358
15.1.2.3 Breakdown of primary interviews 358
15.1.2.4 Insights from primary experts 359
15.2 RESEARCH METHODOLOGY DESIGN 359
15.3 MARKET SIZE ESTIMATION 360
15.4 DATA TRIANGULATION 364
15.5 RESEARCH ASSUMPTIONS 364
15.6 RESEARCH LIMITATIONS 365
15.6.1 METHODOLOGY-RELATED 365
15.6.2 SCOPE-RELATED 365
15.7 RISK ASSESSMENT 366
16 APPENDIX 367
16.1 DISCUSSION GUIDE 367
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 373
16.3 CUSTOMIZATION OPTIONS 375
16.4 RELATED REPORTS 375
16.5 AUTHOR DETAILS 376

ページTOPに戻る

List of Tables/Graphs

TABLE 1 EXCHANGE RATES CONSIDERED FOR CONVERTING CURRENCIES TO USD 35
TABLE 2 MEDICAL SIMULATION MARKET: IMPACT OF PORTER’S FIVE FORCES 55
TABLE 3 MEDICAL SIMULATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM 60
TABLE 4 INDICATIVE PRICING ANALYSIS OF MEDICAL SIMULATION PRODUCTS, BY KEY PLAYER, 2025 61
TABLE 5 INDICATIVE PRICING ANALYSIS OF MEDICAL SIMULATION PRODUCTS,
BY REGION, 2025 61
TABLE 6 MEDICAL SIMULATION MARKET: LIST OF KEY CONFERENCES & EVENTS,
2026?2027 62
TABLE 7 US ADJUSTED RECIPROCAL TARIFF RATES 66
TABLE 8 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR MEDICAL SIMULATION MARKET 74
TABLE 9 MEDICAL SIMULATION MARKET: LIST OF PATENTS/PATENT APPLICATIONS 75
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 88
TABLE 16 KEY BUYING CRITERIA, BY END USER 89
TABLE 17 UNMET NEEDS IN MEDICAL SIMULATION MARKET 90
TABLE 18 END-USER EXPECTATIONS IN MEDICAL SIMULATION MARKET 91
TABLE 19 MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 93
TABLE 20 HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,
2024?2031 (USD MILLION) 94
TABLE 21 HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY REGION,
2024?2031 (USD MILLION) 94
TABLE 22 KEY PLAYERS OFFERING PATIENT SIMULATORS 95
TABLE 23 PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 96
TABLE 24 PATIENT SIMULATORS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 97
TABLE 25 PATIENT SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 97
TABLE 26 KEY MARKET PLAYERS OFFERING HIGH-FIDELITY PATIENT SIMULATORS 98
TABLE 27 HIGH-FIDELITY PATIENT SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 98
TABLE 28 KEY MARKET PLAYERS OFFERING MEDIUM-FIDELITY PATIENT SIMULATORS 99
TABLE 29 MEDIUM-FIDELITY PATIENT SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 100
TABLE 30 KEY MARKET PLAYERS OFFERING LOW-FIDELITY PATIENT SIMULATORS 101
TABLE 31 LOW-FIDELITY PATIENT SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 101
TABLE 32 PATIENT SIMULATORS FOR LAPAROSCOPIC SURGICAL SIMULATORS MARKET,
BY REGION, 2024?2031 (USD MILLION) 102
TABLE 33 PATIENT SIMULATORS FOR GYNECOLOGY SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 103
TABLE 34 PATIENT SIMULATORS FOR CARDIOVASCULAR SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 104
TABLE 35 PATIENT SIMULATORS FOR ORTHOPEDIC SURGICAL SIMULATORS MARKET,
BY REGION, 2024?2031 (USD MILLION) 105
TABLE 36 PATIENT SIMULATORS FOR SPINE SURGICAL SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 105
TABLE 37 PATIENT SIMULATORS FOR ENDOVASCULAR SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 106
TABLE 38 PATIENT SIMULATORS FOR OTHER PATIENT SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 107
TABLE 39 KEY MARKET PLAYERS OFFERING TASK TRAINERS 108
TABLE 40 TASK TRAINERS MARKET, BY REGION, 2024?2031 (USD MILLION) 108
TABLE 41 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 109
TABLE 42 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 110
TABLE 43 KEY MARKET PLAYERS OFFERING LAPAROSCOPIC SURGICAL SIMULATORS 110
TABLE 44 LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 111
TABLE 45 KEY MARKET PLAYERS OFFERING GYNECOLOGY SURGICAL SIMULATORS 112
TABLE 46 GYNECOLOGY SURGICAL SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 112
TABLE 47 KEY MARKET PLAYERS OFFERING CARDIOVASCULAR SURGICAL SIMULATORS 113
TABLE 48 CARDIOVASCULAR SURGICAL SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 113
TABLE 49 KEY MARKET PLAYERS OFFERING ORTHOPEDIC SURGICAL SIMULATORS 114
TABLE 50 ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 114
TABLE 51 KEY MARKET PLAYERS OFFERING SPINE SURGICAL SIMULATORS 115
TABLE 52 SPINE SURGICAL SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 115
TABLE 53 KEY MARKET PLAYERS OFFERING ENDOVASCULAR SURGICAL SIMULATORS 116
TABLE 54 ENDOVASCULAR SURGICAL SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 116
TABLE 55 KEY MARKET PLAYERS OFFERING OTHER INTERVENTIONAL/SURGICAL SIMULATORS 117
TABLE 56 OTHER INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY REGION,
2024?2031 (USD MILLION) 117
TABLE 57 KEY MARKET PLAYERS OFFERING ULTRASOUND SIMULATORS 118
TABLE 58 ULTRASOUND SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 118
TABLE 59 KEY PLAYERS OFFERING DENTAL SIMULATORS 119
TABLE 60 DENTAL SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 119
TABLE 61 KEY PLAYERS OFFERING EYE SIMULATORS 120
TABLE 62 EYE SIMULATORS MARKET, BY REGION, 2024?2031 (USD MILLION) 120
TABLE 63 KEY PLAYERS OFFERING WEB-BASED SIMULATORS 121
TABLE 64 WEB-BASED SIMULATION MARKET, BY REGION, 2024?2031 (USD MILLION) 121
TABLE 65 KEY MARKET PLAYERS OFFERING HEALTHCARE SIMULATION SOFTWARE 122
TABLE 66 HEALTHCARE SIMULATION SOFTWARE MARKET, BY REGION,
2024?2031 (USD MILLION) 123
TABLE 67 SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 123
TABLE 68 SIMULATION TRAINING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 124
TABLE 69 KEY MARKET PLAYERS OFFERING VENDOR-BASED TRAINING SERVICES 124
TABLE 70 VENDOR-BASED TRAINING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 125
TABLE 71 KEY PLAYERS OFFERING EDUCATIONAL SOCIETY SIMULATORS 125
TABLE 72 EDUCATIONAL SOCIETIES MARKET, BY REGION, 2024?2031 (USD MILLION) 126
TABLE 73 KEY MARKET PLAYERS OFFERING CUSTOM CONSULTING SERVICES 126
TABLE 74 CUSTOM CONSULTING SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 127
TABLE 75 MEDICAL SIMULATION MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 129
TABLE 76 OFFERINGS IN MEDICAL SIMULATION MARKET FOR VIRTUAL PATIENT SIMULATION 130
TABLE 77 VIRTUAL PATIENT SIMULATION MARKET, BY REGION, 2024?2031 (USD MILLION) 130
TABLE 78 OFFERINGS IN MEDICAL SIMULATION MARKET FOR 3D PRINTING 131
TABLE 79 3D PRINTING MARKET, BY REGION, 2024?2031 (USD MILLION) 132
TABLE 80 OFFERINGS IN MEDICAL SIMULATION MARKET FOR PROCEDURAL REHEARSAL TECHNOLOGY MARKET 133
TABLE 81 PROCEDURAL REHEARSAL TECHNOLOGY MARKET, BY REGION,
2024?2031 (USD MILLION) 133
TABLE 82 MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 135
TABLE 83 OFFERINGS IN MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTES 136
TABLE 84 MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTES, BY REGION,
2024?2031 (USD MILLION) 136
TABLE 85 OFFERINGS IN MEDICAL SIMULATION MARKET FOR HOSPITALS 137
TABLE 86 MEDICAL SIMULATION MARKET FOR HOSPITALS, BY REGION,
2024?2031 (USD MILLION) 137
TABLE 87 OFFERINGS IN MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS 138
TABLE 88 MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY REGION, 2024?2031 (USD MILLION) 139
TABLE 89 OFFERINGS IN MEDICAL SIMULATION MARKET FOR OTHER END USERS 139
TABLE 90 MEDICAL SIMULATION MARKET FOR OTHER END USERS, BY REGION,
2024?2031 (USD MILLION) 140
TABLE 91 MEDICAL SIMULATION MARKET, BY REGION, 2024?2031 (USD MILLION) 142
TABLE 92 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 144
TABLE 93 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 144
TABLE 94 NORTH AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 144
TABLE 95 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 145
TABLE 96 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 145
TABLE 97 NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 146
TABLE 98 NORTH AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2024?2031 (USD MILLION) 146
TABLE 99 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 146
TABLE 100 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 147
TABLE 101 US: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 148
TABLE 102 US: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,
2024?2031 (USD MILLION) 148
TABLE 103 US: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 149
TABLE 104 US: PATIENT SIMULATORS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 149
TABLE 105 US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 150
TABLE 106 US: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 150
TABLE 107 US: MEDICAL SIMULATION MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 150
TABLE 108 US: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 151
TABLE 109 CANADA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 152
TABLE 110 CANADA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 152
TABLE 111 CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 152
TABLE 112 CANADA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 153
TABLE 113 CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 153
TABLE 114 CANADA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 154
TABLE 115 CANADA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 154
TABLE 116 CANADA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 154
TABLE 117 EUROPE: MEDICAL SIMULATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 156
TABLE 118 EUROPE: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 156
TABLE 119 EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 157
TABLE 120 EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 157
TABLE 121 EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 158
TABLE 122 EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 158
TABLE 123 EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 159
TABLE 124 EUROPE: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 159
TABLE 125 EUROPE: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 159
TABLE 126 GERMANY: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 161
TABLE 127 GERMANY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 161
TABLE 128 GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 162
TABLE 129 GERMANY: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 162
TABLE 130 GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 163
TABLE 131 GERMANY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 163
TABLE 132 GERMANY: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 164
TABLE 133 GERMANY: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 164
TABLE 134 FRANCE: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 165
TABLE 135 FRANCE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 165
TABLE 136 FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 165
TABLE 137 FRANCE: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 166
TABLE 138 FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 166
TABLE 139 FRANCE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 167
TABLE 140 FRANCE: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 167
TABLE 141 FRANCE: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 167
TABLE 142 UK: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 169
TABLE 143 UK: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,
2024?2031 (USD MILLION) 169
TABLE 144 UK: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 169
TABLE 145 UK: PATIENT SIMULATORS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 170
TABLE 146 UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 170
TABLE 147 UK: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 171
TABLE 148 UK: MEDICAL SIMULATION MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 171
TABLE 149 UK: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 171
TABLE 150 ITALY: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 172
TABLE 151 ITALY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 173
TABLE 152 ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 173
TABLE 153 ITALY: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 174
TABLE 154 ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 174
TABLE 155 ITALY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 175
TABLE 156 ITALY: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 175
TABLE 157 ITALY: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 175
TABLE 158 SPAIN: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 176
TABLE 159 SPAIN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 177
TABLE 160 SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 177
TABLE 161 SPAIN: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 178
TABLE 162 SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 178
TABLE 163 SPAIN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 179
TABLE 164 SPAIN: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 179
TABLE 165 SPAIN: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 179
TABLE 166 REST OF EUROPE: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 180
TABLE 167 REST OF EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 181
TABLE 168 REST OF EUROPE: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 181
TABLE 169 REST OF EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 182
TABLE 170 REST OF EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 182
TABLE 171 REST OF EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2024?2031 (USD MILLION) 183
TABLE 172 REST OF EUROPE: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 183
TABLE 173 REST OF EUROPE: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 183
TABLE 174 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 185
TABLE 175 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 185
TABLE 176 ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 186
TABLE 177 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 186
TABLE 178 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 187
TABLE 179 ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 187
TABLE 180 ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 188
TABLE 181 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 188
TABLE 182 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 188
TABLE 183 CHINA: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 190
TABLE 184 CHINA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 190
TABLE 185 CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 190
TABLE 186 CHINA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 191
TABLE 187 CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 191
TABLE 188 CHINA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 192
TABLE 189 CHINA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 192
TABLE 190 CHINA: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 192
TABLE 191 JAPAN: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 193
TABLE 192 JAPAN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 194
TABLE 193 JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 194
TABLE 194 JAPAN: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 195
TABLE 195 JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 195
TABLE 196 JAPAN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 196
TABLE 197 JAPAN: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 196
TABLE 198 JAPAN: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 196
TABLE 199 INDIA: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 197
TABLE 200 INDIA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 198
TABLE 201 INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 198
TABLE 202 INDIA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 199
TABLE 203 INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 199
TABLE 204 INDIA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 200
TABLE 205 INDIA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 200
TABLE 206 INDIA: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 200
TABLE 207 AUSTRALIA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 201
TABLE 208 AUSTRALIA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 202
TABLE 209 AUSTRALIA: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 202
TABLE 210 AUSTRALIA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 203
TABLE 211 AUSTRALIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 203
TABLE 212 AUSTRALIA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 204
TABLE 213 AUSTRALIA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 204
TABLE 214 AUSTRALIA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 204TABLE 215 SOUTH KOREA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 205
TABLE 216 SOUTH KOREA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 206
TABLE 217 SOUTH KOREA: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 206
TABLE 218 SOUTH KOREA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 207
TABLE 219 SOUTH KOREA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 207
TABLE 220 SOUTH KOREA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 208
TABLE 221 SOUTH KOREA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 208
TABLE 222 SOUTH KOREA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 208
TABLE 223 REST OF ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 209
TABLE 224 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 210
TABLE 225 REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 210
TABLE 226 REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 211
TABLE 227 REST OF ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 211
TABLE 228 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 212
TABLE 229 REST OF ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 212
TABLE 230 REST OF ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 212
TABLE 231 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 213
TABLE 232 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 214
TABLE 233 LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 214
TABLE 234 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 214
TABLE 235 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 215
TABLE 236 LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 215
TABLE 237 LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2024?2031 (USD MILLION) 216
TABLE 238 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 216
TABLE 239 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 216
TABLE 240 BRAZIL: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 218
TABLE 241 BRAZIL: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 218
TABLE 242 BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 218
TABLE 243 BRAZIL: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 219
TABLE 244 BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 219
TABLE 245 BRAZIL: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 220
TABLE 246 BRAZIL: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 220
TABLE 247 BRAZIL: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 220
TABLE 248 MEXICO: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 221
TABLE 249 MEXICO: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 222
TABLE 250 MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 222
TABLE 251 MEXICO: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 223
TABLE 252 MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 223
TABLE 253 MEXICO: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 254 MEXICO: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 224
TABLE 255 MEXICO: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 224
TABLE 256 REST OF LATIN AMERICA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 225
TABLE 257 REST OF LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 226
TABLE 258 REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 226
TABLE 259 REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 227
TABLE 260 REST OF LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 227
TABLE 261 REST OF LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 228
TABLE 262 REST OF LATIN AMERICA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 228
TABLE 263 REST OF LATIN AMERICA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 228
TABLE 264 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 229
TABLE 265 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 229
TABLE 266 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 230
TABLE 267 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 230
TABLE 268 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 231
TABLE 269 MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 231
TABLE 270 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 232
TABLE 271 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 232
TABLE 272 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 232
TABLE 273 GCC COUNTRIES: MEDICAL SIMULATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 233
TABLE 274 GCC COUNTRIES: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 234
TABLE 275 GCC COUNTRIES: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 234
TABLE 276 GCC COUNTRIES: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 234
TABLE 277 GCC COUNTRIES: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 235
TABLE 278 GCC COUNTRIES: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 235
TABLE 279 GCC COUNTRIES: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2024?2031 (USD MILLION) 236
TABLE 280 GCC COUNTRIES: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 236
TABLE 281 GCC COUNTRIES: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 236
TABLE 282 SAUDI ARABIA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 237
TABLE 283 SAUDI ARABIA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 238
TABLE 284 SAUDI ARABIA: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 238
TABLE 285 SAUDI ARABIA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 239
TABLE 286 SAUDI ARABIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 239
TABLE 287 SAUDI ARABIA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 240
TABLE 288 SAUDI ARABIA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 240
TABLE 289 SAUDI ARABIA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 240
TABLE 290 UAE: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 241
TABLE 291 UAE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,
2024?2031 (USD MILLION) 242
TABLE 292 UAE: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 242
TABLE 293 UAE: PATIENT SIMULATORS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 243
TABLE 294 UAE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 243
TABLE 295 UAE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 244
TABLE 296 UAE: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 244
TABLE 297 UAE: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 244
TABLE 298 REST OF GCC COUNTRIES: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 245
TABLE 299 REST OF GCC COUNTRIES: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 246
TABLE 300 REST OF GCC COUNTRIES: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 246
TABLE 301 REST OF GCC COUNTRIES: PATIENT SIMULATORS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 247
TABLE 302 REST OF GCC COUNTRIES: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 247
TABLE 303 REST OF GCC COUNTRIES: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 248
TABLE 304 REST OF GCC COUNTRIES: MEDICAL SIMULATION MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 248
TABLE 305 REST OF GCC COUNTRIES: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 248
TABLE 306 SOUTH AFRICA: MEDICAL SIMULATION MARKET, BY OFFERING,
2024?2031 (USD MILLION) 249
TABLE 307 SOUTH AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 250
TABLE 308 SOUTH AFRICA: PATIENT SIMULATORS MARKET, BY TYPE,
2024?2031 (USD MILLION) 250
TABLE 309 SOUTH AFRICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 251
TABLE 310 SOUTH AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 251
TABLE 311 SOUTH AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 252
TABLE 312 SOUTH AFRICA: MEDICAL SIMULATION MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 252
TABLE 313 SOUTH AFRICA: MEDICAL SIMULATION MARKET, BY END USER,
2024?2031 (USD MILLION) 252
TABLE 314 REST OF MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY OFFERING, 2024?2031 (USD MILLION) 253
TABLE 315 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2024?2031 (USD MILLION) 254
TABLE 316 REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 254
TABLE 317 REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 255
TABLE 318 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2024?2031 (USD MILLION) 255
TABLE 319 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 256
TABLE 320 REST OF MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET,
BY TECHNOLOGY, 2024?2031 (USD MILLION) 256
TABLE 321 REST OF MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY END USER, 2024?2031 (USD MILLION) 256
TABLE 322 MEDICAL SIMULATION MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2023?MAY 2026 257
TABLE 323 MEDICAL SIMULATION MARKET: DEGREE OF COMPETITION 262
TABLE 324 MEDICAL SIMULATION MARKET: REGION FOOTPRINT 268
TABLE 325 MEDICAL SIMULATION MARKET: PRODUCT & SERVICE FOOTPRINT 269
TABLE 326 MEDICAL SIMULATION MARKET: TECHNOLOGY FOOTPRINT 270
TABLE 327 MEDICAL SIMULATION MARKET: END-USER FOOTPRINT 270
TABLE 328 MEDICAL SIMULATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 273
TABLE 329 MEDICAL SIMULATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION 273
TABLE 330 MEDICAL SIMULATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY TECHNOLOGY AND END USER 274
TABLE 331 MEDICAL SIMULATION MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023?MAY 2026 274
TABLE 332 MEDICAL SIMULATION MARKET: DEALS, JANUARY 2023?MAY 2026 275
TABLE 333 SURGICAL SCIENCE SWEDEN AB: COMPANY OVERVIEW 277
TABLE 334 SURGICAL SCIENCE SWEDEN AB: PRODUCTS OFFERED 278
TABLE 335 SURGICAL SCIENCE SWEDEN AB: PRODUCT ENHANCEMENTS,
JANUARY 2023?MAY 2026 279
TABLE 336 SURGICAL SCIENCE SWEDEN AB: DEALS, JANUARY 2023?MAY 2026 279
TABLE 337 LAERDAL MEDICAL: COMPANY OVERVIEW 281
TABLE 338 LAERDAL MEDICAL: PRODUCTS OFFERED 281
TABLE 339 LAERDAL MEDICAL: PRODUCT LAUNCHES, JANUARY 2023?MAY 2026 285
TABLE 340 LAERDAL MEDICAL: DEALS, JANUARY 2023?MAY 2026 285
TABLE 341 GAUMARD SCIENTIFIC: COMPANY OVERVIEW 287
TABLE 342 GAUMARD SCIENTIFIC: PRODUCTS OFFERED 287
TABLE 343 GAUMARD SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2023?MAY 2026 295
TABLE 344 GAUMARD SCIENTIFIC: DEALS, JANUARY 2023?MAY 2026 295
TABLE 345 KYOTO KAGAKU CO., LTD.: COMPANY OVERVIEW 297
TABLE 346 KYOTO KAGAKU CO., LTD.: PRODUCTS OFFERED 297
TABLE 347 LIMBS & THINGS LTD: COMPANY OVERVIEW 303
TABLE 348 LIMBS & THINGS LTD.: PRODUCTS OFFERED 303
TABLE 349 LIMBS & THINGS LTD.: PRODUCT LAUNCHES, JANUARY 2023?MAY 2026 306
TABLE 350 LIMBS & THINGS LTD.: DEALS, JANUARY 2023?MAY 2026 307
TABLE 351 MENTICE AB: COMPANY OVERVIEW 308
TABLE 352 MENTICE AB: PRODUCTS OFFERED 309
TABLE 353 MENTICE AB: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023?MAY 2026 311
TABLE 354 MENTICE AB: DEALS, JANUARY 2023?MAY 2026 311
TABLE 355 SIMULAB CORPORATION: COMPANY OVERVIEW 313
TABLE 356 SIMULAB CORPORATION: PRODUCTS OFFERED 313
TABLE 357 SIMULAB CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2023 ? MAY 2026 319
TABLE 358 SIMULAIDS: COMPANY OVERVIEW 320
TABLE 359 SIMULAIDS: PRODUCTS OFFERED 320
TABLE 360 SIMULAIDS: PRODUCT LAUNCHES, JANUARY 2023?MAY 2026 326
TABLE 361 OPERATIVE EXPERIENCE, INC.: COMPANY OVERVIEW 327
TABLE 362 OPERATIVE EXPERIENCE, INC.: PRODUCTS OFFERED 327
TABLE 363 OPERATIVE EXPERIENCE, INC.: OTHER DEVELOPMENTS,
JANUARY 2023?MAY 2026 328
TABLE 364 ELEVATE HEALTHCARE: COMPANY OVERVIEW 329
TABLE 365 ELEVATE HEALTHCARE: PRODUCTS OFFERED 330
TABLE 366 ANATOMAGE: COMPANY OVERVIEW 331
TABLE 367 ANATOMAGE: PRODUCTS OFFERED 331
TABLE 368 ANATOMAGE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2023?MAY 2026 332
TABLE 369 ANATOMAGE: OTHER DEVELOPMENTS, JANUARY 2023?MAY 2026 333
TABLE